Shuyu Cai
NHC Key Laboratory Of Nuclear Medicine, Jiangsu Key Laboratory Of Molecular Nuclear Medicine
Wuxi, 214063, China
Wuxi, 214063, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Preliminary Study of a Novel 68Ga-Labeled Probe Targeting Neuropilin-1 for Tumor Diagnosis.
Journal: Molecular pharmaceutics
Published: February 11, 2025
Development and evaluation of biphenyl-based small-molecule radiotracers for PET imaging of PD-L1 in tumor.
Journal: Bioorganic & medicinal chemistry letters
Published: October 14, 2024
Development of Granzyme B-targeted Smart Positron Emission Tomography Probes for Monitoring Tumor Early Response to Immunotherapy.
Journal: ACS nano
Published: July 13, 2024
Lysosome-targeting and legumain-triggered 68Ga-labeled probe for enhanced tumor PET imaging.
Journal: Biochemical and biophysical research communications
Published: November 21, 2023
Preclinical evaluation of 68 Ga-labeled peptide CK2 for PET imaging of NRP-1 expression in vivo.
Journal: European journal of nuclear medicine and molecular imaging
Published: August 17, 2023
Retraction Note: The PI3K/mTOR Dual Inhibitor BEZ235 Nanoparticles Improve Radiosensitization of Hepatoma Cells Through Apoptosis and Regulation DNA Repair Pathway.
Journal: Nanoscale research letters
Published: December 16, 2021
LY3214996 relieves acquired resistance to sorafenib in hepatocellular carcinoma cells.
Journal: International journal of medical sciences
Published: July 29, 2020
The PI3K/mTOR dual inhibitor BEZ235 nanoparticles improve radiosensitization of hepatoma cells through apoptosis and regulation DNA repair pathway.
Journal: Nanoscale research letters
Published: September 17, 2019
BEZ235 increases sorafenib inhibition of hepatocellular carcinoma cells by suppressing the PI3K/AKT/mTOR pathway.
Journal: American journal of translational research
Published: April 16, 2019
BEZ235 enhances chemosensitivity of paclitaxel in hepatocellular carcinoma through inhibiting the PI3K/Akt/mTOR pathway.
Journal: American journal of translational research
Published: April 07, 2019
Enhanced delivery of sorafenib with anti-GPC3 antibody-conjugated TPGS-b-PCL/Pluronic P123 polymeric nanoparticles for targeted therapy of hepatocellular carcinoma.
Journal: Materials science & engineering. C, Materials for biological applications
Published: August 22, 2017
Last Updated: 09/26/2026